Lamotrigine induced Steven Johnson syndrome: A case report in Al Batool teaching hospital in Diyala governorate

Lamotrigine induced Steven Johnson syndrome: A case report in Al Batool teaching hospital in Diyala governorate

Show other versions (1)

Background: Steven Johnson syndrome (SJS) is a rare disease that is characterized by acute cutaneous manifestation represented by eruptions of the skin and the mucosal membranes. SJS is an immune-mediated disease, a hypersensitive reaction, characterized by hyperpigmentation of the mucous membranes...

Full description

Bibliographic Details
Main Authors:	Sura Qais Mahmood Almaroof, Issam Tariq Abdul Wahaab
Format:	Article
Language:	English
Published:	College of medicine/ University of Diyala 2021-06-01
Series:	Diyala Journal of Medicine
Subjects:	Lamotrigine; epidermal detachment; toxic epidermal necrosis ; Stevens johnson syndrome
Online Access:	https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/738

Similar Items

Lamotrigine induced Steven Johnson syndrome: A case report in Al Batool teaching hospital in Diyala governorate
by: Sura Qais Mahmood Almaroof, et al.
Published: (2021-06-01)

A Retrospective Study: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Yuli Wahyu Rahmawati, et al.
Published: (2016-10-01)

A case of Stevens-Johnson syndrome treated with oral cyclosporine
by: Victoria Griffith, et al.
Published: (2023-01-01)

A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
by: Hua-Ching Chang, et al.
Published: (2022-08-01)

Genitourinary management and follow-up for patients with Stevens-Johnson syndrome/toxic epidermal necrolysis
by: Gina T. Baaklini, et al.
Published: (2023-04-01)

Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review
by: Gábor Tóth, et al.
Published: (2023-05-01)

Syndroma Stevens-Johnson - toxic epidermal necrolysis overlap associated with carbamazepine in patient with secondary epilepsy caused by brain tumor (Glioblastoma multiforme)
by: Vojvodić A., et al.
Published: (2015-01-01)

A retrospective analysis of infections and antibiotic treatment in patients with Stevens–Johnson syndrome and toxic epidermal necrolysis
by: Min Diao, et al.
Published: (2020-01-01)

Cyclosporine monotherapy in pediatric Stevens–Johnson syndrome and toxic epidermal necrolysis: Preserving sepsis indicators while promoting recovery
by: Simran S Tuli, et al.
Published: (2023-01-01)

Stevens Johnson syndrome and toxic epidermal necrolysis – an Australian analysis of treatment outcomes and mortality
by: Alain Khoi Tran, et al.
Published: (2019-10-01)

Daunorubicin induced Stevens‐Johnson syndrome: A case report
by: Preeti Shakya, et al.
Published: (2021-07-01)

Lamotrigine, a Miscreant in Toxic Epidermal Necrolysis: A Rare Case Report
by: Mahima MAKHIJA, et al.
Published: (2023-03-01)

The Profiles of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Patients in Tertiary Hospital
by: William Andrew Isaac, et al.
Published: (2021-07-01)

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash
by: Eda Ataseven, et al.
Published: (2016-05-01)

Investigation of Monnose-Binding Lectin gene Polymorphism in Patients with Erythema Multiforme, Stevens-Johnson Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Syndrome
by: Sevil Toka, et al.
Published: (2012-09-01)

Stevens-Johnson syndrome/toxic epidermal necrolysis overlap triggered by ethosuximide: a rare pediatric report
by: Sandra Soares-Cardoso, et al.
Published: (2023-04-01)

Ventilatory support in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2022-01-01)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management
by: Robert Frantz, et al.
Published: (2021-08-01)

Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review
by: Shan Zhang, et al.
Published: (2020-01-01)

Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review
by: Ajay N. Sharma, BS, et al.
Published: (2020-09-01)

Gambaran Klinis Steven Johnson Syndrome dan Toxic Epidermal Necrolysis pada Pasien Anak
by: Annisa Fitriana, et al.
Published: (2018-09-01)

Pemphigus vulgaris mimicking Steven-Johnson syndrome/toxic epidermal necrolysis: report of an unusual case
by: Latifah Albrahim, et al.
Published: (2023-05-01)

Dermatological adverse drug reactions with particular reference to Steven-Johnson syndrome and toxic epidermal necrolysis
by: Muddasir Sharief Banday, et al.
Published: (2023-01-01)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis, A Review of Pathogenesis, Clinical Features, Diagnosis and Treatment
by: Martyna Rozenbajgier, et al.
Published: (2022-09-01)

Oxcarbazepine-induced stevens johnson syndrome and toxic epidermal necrolysis overlap
by: Sangha Mitra Godi, et al.
Published: (2022-01-01)

Genetic Markers and Danger Signals in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Wen-Hung Chung, et al.
Published: (2010-01-01)

Stevens-Johnson syndrome. Presentation of a patient
by: Dianelí Lorely Reyes Hernández, et al.
Published: (2015-12-01)

Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy
by: Lin M, et al.
Published: (2024-04-01)

Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification
by: Blake Jeffrey McKinley, et al.
Published: (2023-06-01)

Drugs Induced Stevens-Johnson Syndrome
by: Elif ÖNDER, et al.
Published: (2010-05-01)

Stevens–Johnson syndrome and toxic epidermal necrolysis: A fresh look at an old foe
by: Sowmya Kaimal, et al.
Published: (2023-01-01)

Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis
by: Jiali Cao, et al.
Published: (2023-05-01)

PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
by: M. Ghaffarpour, et al.
Published: (2005-04-01)

Suçiçeği ile ilişkili Stevens-Johnson sendromu
by: Hasibe Artaç, et al.
Published: (2013-01-01)

Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Qingzi Yan, et al.
Published: (2023-10-01)

Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study
by: Yingyi Liu, et al.
Published: (2023-07-01)

Case report: Alpelisib-induced Stevens–Johnson syndrome
by: Christine Jane Kurian, et al.
Published: (2022-09-01)

Evaluation of patients with erythema exudativum multiforme, Stevens‐Johnson syndrome, and toxic epidermal necrolysis treated at our department during the previous 9‐year period
by: Midori Kawasaki‐Nagano, et al.
Published: (2022-10-01)

Sertraline induced Stevens-Johnson syndrome - A case series
by: Ankit Halder, et al.
Published: (2023-01-01)

Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
by: Thandekile C. Manzini, et al.
Published: (2016-12-01)